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REACTION OF PSORIASIS FOLLOWING USE OF GAMMA GLOBULIN*
GusTAvus H. KLINCK, Ja., M.D.**
Many forms of "foreign protein" therapy, "immune blood" transfusions, etc. have been
tried in the treatment of psoriasis. I found no record of the use of gamma globlulin in this
disease.
This is a preliminary report of clinical changes in lesions characteristic of psoriasis,
following multiple intramuscular injections of gamma globulin. The history of complete
disappearance of the lesions of psoriasis for about 16 months, following a severe attack of
measles in one patient, suggested the use of gamma globulin as a therapeutic agent in this
refractory disease.
A 30 year old man had had very numerous lesions characteristic of psoriasis since the
age of 10, except during the 16 months period following measles during adolescence. At
the age of 30 he was given 5 ml of gamma globulin once a week. At the end of 3 weeks there
was definite improvement and after 6 weeks the patient was entirely free of lesions. All
treatment was suspended and the skin remained clear for about 3 months. At the end of
2 years, with no interim treatment, several lesions had appeared but neither their number
nor their size reached the magnitude observed before treatment.
In an attempt to ascertain whether or not gamma globulin might influence psoriasis in
others, 5 additional patients with the same disorder were given injections of this material.
Thus a total of 6 cases has been treated.
Case 1 and Case 2 showed complete clearing of lesions, and the latter is free of lesions at
the time of writing (3 months after the last dose).
Case 3—cleared slowly at first, but several lesions cleared completely and gradual im-
provement is in progress 3 months after the last injection.
Case 4—of widespread, long-standing psoriasis, demonstrated complete clearing of
almost all of the lesions. Improvement continued for 8 weeks following the last dose, but
gradually the lesions recurred.
Case 5 showed definite improvement following 10 ml of gamma globulin administered
daily for 2 weeks. Encouraging changes continued in the lesions for several weeks after
the last dose, but then there was gradual recurrence.
Case 6—showed no improvement after receiving a total of 8 ml. gamma globulin each
week for 6 weeks followed by 16 ml each week for 3 weeks.
Unfortunately in these preliminary studies the dosage and time intervals varied so
greatly that no accurate estimate can be advanced regarding the necessary or effective
anges. In some cases the lesions disappeared completely or in part when a total of 16 ml
were given each week. One patient, with several lesions of many years' duration, received
4 ml each week for several weeks, and later more frequent as well as larger doses. He was
under treatment for 7 months, and many of the lesions disappeared completely.
Another patient who had had lesions for about 1 year demonstrated complete clearing
within 4 weeks after receiving 10 ml daily for 10 days. While the most effective regimen
cannot be determined without further study, there are indications that three doses each
week are most effective. Weekly doses did not appear to be efficacious. It appeared that
lesions on exposed parts, such as hands, face and neck, responded more rapidly than others.
Careful thought was given to the possibility of sensitizing patients by the parenteral
injection of gamma globulin, but no evidence that sensitivity will be produced under the
conditions of administration as set forth was found.
The writer is not prepared to advance a theory as to the mode of action of gamma glob-.
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nun in psoriais. The patient who did not respond to treatment weighed 104.6 kg. (230
ibs). It is possible that there is a relation between size of dose and body weight, since all
the patients with severe lesions who responded weighed less than 72.7 kg. (160 Ibs). There
is a possibility that psoriasis is influenced by the level of antibodies in an individual as
suggested by disappearance of lesions in 1 case after measles. No attempt was made to
estimate the amount of gamma globulin in the blood of any of the patients before, during,
or after treatment.
While no conclusions can be drawn from such a small series, and while fully aware of the
erratic course and many inexplicable remissions observed in any series of psoriatics, it
appeared to me that the results with gamma globulin were sufficiently encouraging to
warrant the submission of this method for trial and evaluation by other observers.
Note: Almost all of the gamma globulin used in these trials was furnished through the
courtesy of Cutter Laboratories, Berkeley, California.
